Novartis may have abandoned one Sjögren's syndrome asset this year, but it looks like the drugmaker has a winner on its hands ...

Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III trials to demonstrate statistically significant reduction in disease activity for Sjögren's ...

Kris Aquino announced Monday she will enter a six-month preventive isolation period as part of her treatment for multiple ...

Novartis today announced positive top-line results from its Phase III trials evaluating ianalumab (VAY736) in adults with active Sjögren's disease. Both trials met the primary endpoint of ...

As Canada contends with ever-evolving claims on the right to die, the demand for euthanasia has begun to outstrip the ...

The use of cell therapy in rheumatology is likely to expand considerably in the coming years, according to a presenter at the ...

Vitamin D is sometimes nicknamed the “sunshine vitamin” because your skin makes it when you’re out in the sun. You can also ...

Transplanting gut bacteria from healthy people reduced pain associated with fibromyalgia in mice and patients, offering a ...